Drug profile · INN
bisacodyl
DULCOLAX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
bisacodyl (DULCOLAX) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN bisacodyl
Brand DULCOLAX
Route ORAL
Formulation FOR SOLUTION, TABLET, DELAYED RELEASE
Originator Sanofi-aventis Healthcare Pty Ltd
Frequently asked questions
What is bisacodyl?
bisacodyl (DULCOLAX) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for bisacodyl?
DULCOLAX is a marketed brand name for bisacodyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bisacodyl?
bisacodyl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.